MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in airtight containers. Protect from heat and moisture.

Provenance

Compatibility recommendation derived from Perindopril erbumine 8mg tablets (Sandoz Ltd).

Stability Notes

Store in airtight containers. Protect from heat and moisture.

Provenance

Compatibility recommendation derived from Perindopril erbumine 8mg tablets (Sandoz Ltd).

Stability Notes

Store in airtight containers. Protect from heat and moisture.

Provenance

Compatibility recommendation derived from Perindopril erbumine 8mg tablets (Sandoz Ltd).

Stability Notes

Store in airtight containers. Protect from heat and moisture.

Provenance

Compatibility recommendation derived from Perindopril erbumine 8mg tablets (Sandoz Ltd).

Stability Notes

Use airtight and light resistant container.

Provenance

Compatibility information derived from Naprosyn EC 250mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Periostat 20mg tablets (Alliance Pharmaceuticals Ltd).

Stability Notes

Store in airtight containers; protect from light.

Provenance

Compatibility recommendation derived from Pethidine 50mg tablets (Martindale Pharmaceuticals Ltd).

Stability Notes

Store in airtight containers; protect from light.

Provenance

Compatibility recommendation derived from Pethidine 50mg tablets (Martindale Pharmaceuticals Ltd).

Stability Notes

Store in airtight containers; protect from light.

Provenance

Compatibility recommendation derived from Pethidine 50mg tablets (Martindale Pharmaceuticals Ltd).

Stability Notes

Store in airtight containers; protect from light.

Provenance

Compatibility recommendation derived from Pethidine 50mg tablets (Martindale Pharmaceuticals Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.